rs1555574417
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_000088.4(COL1A1):c.859-17_859-16delTAinsGTAGATCAGAAT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000088.4 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL1A1 | NM_000088.4 | c.859-17_859-16delTAinsGTAGATCAGAAT | intron_variant | Intron 12 of 50 | ENST00000225964.10 | NP_000079.2 | ||
COL1A1 | XM_011524341.2 | c.859-17_859-16delTAinsGTAGATCAGAAT | intron_variant | Intron 12 of 47 | XP_011522643.1 | |||
COL1A1 | XM_005257058.5 | c.859-17_859-16delTAinsGTAGATCAGAAT | intron_variant | Intron 12 of 48 | XP_005257115.2 | |||
COL1A1 | XM_005257059.5 | c.859-17_859-16delTAinsGTAGATCAGAAT | intron_variant | Intron 12 of 37 | XP_005257116.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL1A1 | ENST00000225964.10 | c.859-17_859-16delTAinsGTAGATCAGAAT | intron_variant | Intron 12 of 50 | 1 | NM_000088.4 | ENSP00000225964.6 | |||
COL1A1 | ENST00000485870.1 | n.51_52delTAinsGTAGATCAGAAT | non_coding_transcript_exon_variant | Exon 1 of 2 | 3 | |||||
COL1A1 | ENST00000495677.1 | n.586-17_586-16delTAinsGTAGATCAGAAT | intron_variant | Intron 7 of 7 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cardiovascular phenotype Pathogenic:1
The c.859-17_859-16delTAinsGTAGATCAGAAT intronic variant begins 17 nucleotides before coding exon 13 of the COL1A1 gene. This variant results from a deletion of 2 and insertion of 12 nucleotides at nucleotide positions c.859-17 to c.859-16. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). RNA studies have demonstrated that this alteration results in abnormal splicing in the set of samples tested (Ambry internal data). In silico splice site analysis predicts that this alteration will result in the creation or strengthening of a novel splice acceptor site. Based on the available evidence, this alteration is classified as likely pathogenic. -
not provided Uncertain:1
Available data are insufficient to determine the clinical significance of the variant at this time. This variant has been identified in at least one individual with clinical features associated with this gene. This variant has not been reported in large, multi-ethnic general populations. (http://gnomad.broadinstitute.org) Computational tools yielded predictions that this variant may result in the gain of a cryptic splice site without affecting the natural splice sites. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at